ARCHIVES

Satraplatin With Prednisone Reduces Risk Of Disease Progression By 33% In Study

This article is from The Cancer Letter archive.

Vol. 30 No. 3 | March 30, 2007

Download PDF Visit The Full Archive

Related Articles

EntreMed Issued U.S. Patent For Active Parts Of Endostatin.

March 2, 2001

November issue of Business & Regulatory Report, an additional 8 pages, included in this issue.

November 19, 2004

ACS Says New Tax Policy Hurts Charity Funds

April 25, 1980

ONS Adopts Scope Of Oncology Nursing Practice

November 23, 1984

R. Lee Clark Clinic Dedication To Honor M.D. Anderson’s “Architect”

November 13, 1987

Dasatinib, Nilotinib Show Strong Early Results As Frontline Therapy For CML

December 28, 2007